Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 28, 2014; 20(28): 9270-9280
Published online Jul 28, 2014. doi: 10.3748/wjg.v20.i28.9270
Figure 1
Figure 1 Cumulative life-time risk (30-80 years old) of hepatocellular carcinoma.
Figure 2
Figure 2 Cumulative life-time risk. A: Cumulative lifetime risk (30-80 years old) of hepatocellular carcinoma by gender; B: Cumulative lifetime risk (30-80 years old) of hepatocellular carcinoma by hepatitis C virus (HCV) RNA; C: Cumulative lifetime risk (30-80 years old) of hepatocellular carcinoma by serum levels of alanine aminotransferase; D: Cumulative lifetime risk (30-80 years old) of hepatocellular carcinoma by HCV genotype. ALT: Alanine aminotransferase.